This work aims to explore the clinical application of quantitative susceptibility mapping (QSM) in evaluating the haemarrhrosis of heamophilic arthropathy with large heamosiderin. Our results showed that there was strong correlation between QSM and bleeding time, demonstrating that QSM has the potential to be a biomarker in evaluating the intraarticular bleeding of heamophilic arthropathy with large heamosiderin.
This abstract and the presentation materials are available to members only; a login is required.